L’importanza della nutrizione nelle MICI
1 min
11.12.2025
Le malattie infiammatorie intestinali (IBD), tra cui il morbo di Crohn (MC) e la colite ulcerosa (CU), determinano una significativa morbilità...
Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature Review
1 min
05.12.2025
This systematic literature review aimed to identify studies assessing the clinical efficacy and real-world effectiveness of current and emerging...
Presenzialismo lavorativo e capacità di esercizio fisico nelle MICI
1 min
06.11.2025
Le malattie infiammatorie intestinali (MICI) possono avere un impatto significativo sulla produttività lavorativa dell’individuo, portando a fenomeni...
Dealing with IGs Shortages: A Rationalization Plan
2 min
14.06.2024
BACKGROUND: La domanda e il consumo di immunoglobuline (IgG) sono in crescita e ci sono molte difficoltà di approvvigionamento. Lo scopo dello studio...
B- and T- Cell Subset Abnormalities in Monogenic CVID
14.06.2024
L'immunodeficienza comune variabile (CVID) è un gruppo eterogeneo di errori congeniti dell'immunità caratterizzati da ridotte concentrazioni sieriche...
An Expert Opinion: Approach for Gastrointestinal Manifestations of CVID
13.06.2024
L'immunodeficienza comune variabile (CVID) è l'immunodeficienza primaria sintomatica più comune. È caratterizzata da un’alterata differenziazione dei...
The diagnostic and prognostic value of haematologic parameters in multiple myeloma patients
09.10.2023
Abstract Objectives Multiple myeloma (MM) is a malignant disease characterized by a single clonal proliferation of B cell derived plasma cells in the...
A Mobile App to Support Self Management in Patients with Multiple Myeloma or Chronic Lymphocytic Leukemia: Pilot…
09.10.2023
Abstract Background Patients with blood cancer experience serious physical and emotional symptoms throughout their cancer journey. Objective Building...
Chromothripsis detection with multiple myeloma patients based on deep graph learning
02.10.2023
Abstract Motivation Chromothripsis, associated with poor clinical outcomes, is prognostically vital in multiple myeloma. The catastrophic event is...
Potential future direction of measurable residual disease evaluation in multiple myeloma
02.10.2023
Multiple myeloma remains an incurable disease plagued by high relapse rates. Deeper and more sustainable responses however, have been consistently...